Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxyethyl Starch vs. Balanced Crystalloid for Intraoperative Fluid Therapy in Cardiac Surgery
NCT07410988Phase 4Recruiting
- Sponsor
- Seoul National University Hospital
- Start
- Jun 2026
- Primary completion
- Jun 2029
- Modality
- Polymer-based Nanoparticles, Lipid-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of hetastarch in hypovolemia (2 arms), sponsored by Seoul National University Hospital. Primary endpoint: Major Adverse Kidney Events at 7 days. Started Jun 2026; status: recruiting.
02
Drugs
hetastarch
03
Conditions
hypovolemia
Beyond the preview
Go deeper on NCT07410988.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07410988.